Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Integral Diagnostics Ltd. ( (AU:IDX) ).
Integral Diagnostics Limited announced that all resolutions at its Annual General Meeting were passed, reflecting strong shareholder support. The successful resolutions, including the election of directors and approval of financial assistance, indicate stability and continued confidence in the company’s strategic direction.
The most recent analyst rating on (AU:IDX) stock is a Buy with a A$4.00 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics (IDX) is a leading provider of medical imaging services across Australia and New Zealand, employing top radiologists and diagnostic imaging specialists. The company focuses on delivering quality patient care and service through a unique medical leadership model.
Average Trading Volume: 1,249,543
Technical Sentiment Signal: Sell
Current Market Cap: A$954.7M
See more insights into IDX stock on TipRanks’ Stock Analysis page.